Global Drugs for Herpes Labialis (Oral Herpes) Market Insights, Forecast to 2030

Drugs for Herpes Labialis (Oral Herpes) Market

Herpes Labialis (Oral Herpes) is a type of herpes simplex occurring on the lip, i.e. an infection caused by herpes simplex virus (HSV). An outbreak typically causes small blisters or sores on or around the mouth. The sores typically heal within 2–3 weeks, but the herpes virus remains dormant in the facial nerves, following orofacial infection, periodically reactivating (in symptomatic people) to create sores in the same area of the mouth or face at the site of the original infection.

Market Analysis and Insights: Global Drugs for Herpes Labialis (Oral Herpes) Market

Global Drugs for Herpes Labialis (Oral Herpes) key players include GSK, Novartis, Teva, Mylan, Cadila, etc. Global top five manufacturers hold a share about 55%. North America is the largest market, with a share about 35%, followed by Europe, with a share about 30 percent. In terms of product, Rx Drugs is the largest segment, with a share about 90%. And in terms of application, the largest application is Oral, followed by External Use, and Injection, etc.

Report Covers:

This report presents an overview of global market for Drugs for Herpes Labialis (Oral Herpes) market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Drugs for Herpes Labialis (Oral Herpes), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Drugs for Herpes Labialis (Oral Herpes), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drugs for Herpes Labialis (Oral Herpes) revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Drugs for Herpes Labialis (Oral Herpes) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Drugs for Herpes Labialis (Oral Herpes) revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

GSK

Novartis

Teva

Mylan

Cadila

Apotex

Daewoong Pharmaceutical

Livzon

Luoxin

Med shine

Bayer (Campho Phenique)

Blistex

Kelun

Hikma

Haiwang

Carmex

Cipher

Aciclovir

Valacyclovir

Famciclovir

Docosanol

Other

External Use

Oral

Injection

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

China

Asia (excluding China)

Japan

South Korea

China Taiwan

Southeast Asia

India

Latin America, Middle East & Africa

Brazil

Mexico

Turkey

Israel

GCC Countries

Scope of Drugs for Herpes Labialis (Oral Herpes) Market Report

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Drugs for Herpes Labialis (Oral Herpes) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Drugs for Herpes Labialis (Oral Herpes) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, revenue for each segment.

Chapter 8: China by Type, and by Application, revenue for each segment.

Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drugs for Herpes Labialis (Oral Herpes) revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Aciclovir

1.2.3 Valacyclovir

1.2.4 Famciclovir

1.2.5 Docosanol

1.2.6 Other

1.3 Market by Application

1.3.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 External Use

1.3.3 Oral

1.3.4 Injection

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Perspective (2019-2030)

2.2 Global Drugs for Herpes Labialis (Oral Herpes) Growth Trends by Region

2.2.1 Drugs for Herpes Labialis (Oral Herpes) Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Drugs for Herpes Labialis (Oral Herpes) Historic Market Size by Region (2019-2024)

2.2.3 Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Region (2025-2030)

2.3 Drugs for Herpes Labialis (Oral Herpes) Market Dynamics

2.3.1 Drugs for Herpes Labialis (Oral Herpes) Industry Trends

2.3.2 Drugs for Herpes Labialis (Oral Herpes) Market Drivers

2.3.3 Drugs for Herpes Labialis (Oral Herpes) Market Challenges

2.3.4 Drugs for Herpes Labialis (Oral Herpes) Market Restraints

3.1 Global Revenue Drugs for Herpes Labialis (Oral Herpes) by Players

3.1.1 Global Drugs for Herpes Labialis (Oral Herpes) Revenue by Players (2019-2024)

3.1.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Players (2019-2024)

3.2 Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Drugs for Herpes Labialis (Oral Herpes), Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Drugs for Herpes Labialis (Oral Herpes) Market Concentration Ratio

3.4.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drugs for Herpes Labialis (Oral Herpes) Revenue in 2023

3.5 Global Key Players of Drugs for Herpes Labialis (Oral Herpes) Head office and Area Served

3.6 Global Key Players of Drugs for Herpes Labialis (Oral Herpes), Product and Application

3.7 Global Key Players of Drugs for Herpes Labialis (Oral Herpes), Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Drugs for Herpes Labialis (Oral Herpes) Historic Market Size by Type (2019-2024)

4.2 Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Type (2025-2030)

5.1 Global Drugs for Herpes Labialis (Oral Herpes) Historic Market Size by Application (2019-2024)

5.2 Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Application (2025-2030)

6.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size (2019-2030)

6.2 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type

6.2.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2019-2024)

6.2.2 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2025-2030)

6.2.3 North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2019-2030)

6.3 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application

6.3.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2019-2024)

6.3.2 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2025-2030)

6.3.3 North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2019-2030)

6.4 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country

6.4.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024)

6.4.3 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7.1 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size (2019-2030)

7.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Type

7.2.1 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2019-2024)

7.2.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2025-2030)

7.2.3 Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2019-2030)

7.3 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Application

7.3.1 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2019-2024)

7.3.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2025-2030)

7.3.3 Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2019-2030)

7.4 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country

7.4.1 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024)

7.4.3 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8.1 China Drugs for Herpes Labialis (Oral Herpes) Market Size (2019-2030)

8.2 China Drugs for Herpes Labialis (Oral Herpes) Market Size by Type

8.2.1 China Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2019-2024)

8.2.2 China Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2025-2030)

8.2.3 China Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2019-2030)

8.3 China Drugs for Herpes Labialis (Oral Herpes) Market Size by Application

8.3.1 China Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2019-2024)

8.3.2 China Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2025-2030)

8.3.3 China Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2019-2030)

9.1 Asia Drugs for Herpes Labialis (Oral Herpes) Market Size (2019-2030)

9.2 Asia Drugs for Herpes Labialis (Oral Herpes) Market Size by Type

9.2.1 Asia Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2019-2024)

9.2.2 Asia Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2025-2030)

9.2.3 Asia Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2019-2030)

9.3 Asia Drugs for Herpes Labialis (Oral Herpes) Market Size by Application

9.3.1 Asia Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2019-2024)

9.3.2 Asia Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2025-2030)

9.3.3 Asia Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2019-2030)

9.4 Asia Drugs for Herpes Labialis (Oral Herpes) Market Size by Region

9.4.1 Asia Drugs for Herpes Labialis (Oral Herpes) Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2019-2024)

9.4.3 Asia Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10.1 Middle East, Africa, and Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type

10.2.1 Middle East, Africa, and Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application

10.3.1 Middle East, Africa, and Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country

10.4.1 Middle East, Africa, and Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11.1 GSK

11.1.1 GSK Company Details

11.1.2 GSK Business Overview

11.1.3 GSK Drugs for Herpes Labialis (Oral Herpes) Introduction

11.1.4 GSK Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

11.1.5 GSK Recent Developments

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Drugs for Herpes Labialis (Oral Herpes) Introduction

11.2.4 Novartis Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

11.2.5 Novartis Recent Developments

11.3 Teva

11.3.1 Teva Company Details

11.3.2 Teva Business Overview

11.3.3 Teva Drugs for Herpes Labialis (Oral Herpes) Introduction

11.3.4 Teva Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

11.3.5 Teva Recent Developments

11.4 Mylan

11.4.1 Mylan Company Details

11.4.2 Mylan Business Overview

11.4.3 Mylan Drugs for Herpes Labialis (Oral Herpes) Introduction

11.4.4 Mylan Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

11.4.5 Mylan Recent Developments

11.5 Cadila

11.5.1 Cadila Company Details

11.5.2 Cadila Business Overview

11.5.3 Cadila Drugs for Herpes Labialis (Oral Herpes) Introduction

11.5.4 Cadila Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

11.5.5 Cadila Recent Developments

11.6 Apotex

11.6.1 Apotex Company Details

11.6.2 Apotex Business Overview

11.6.3 Apotex Drugs for Herpes Labialis (Oral Herpes) Introduction

11.6.4 Apotex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

11.6.5 Apotex Recent Developments

11.7 Daewoong Pharmaceutical

11.7.1 Daewoong Pharmaceutical Company Details

11.7.2 Daewoong Pharmaceutical Business Overview

11.7.3 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Introduction

11.7.4 Daewoong Pharmaceutical Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

11.7.5 Daewoong Pharmaceutical Recent Developments

11.8 Livzon

11.8.1 Livzon Company Details

11.8.2 Livzon Business Overview

11.8.3 Livzon Drugs for Herpes Labialis (Oral Herpes) Introduction

11.8.4 Livzon Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

11.8.5 Livzon Recent Developments

11.9 Luoxin

11.9.1 Luoxin Company Details

11.9.2 Luoxin Business Overview

11.9.3 Luoxin Drugs for Herpes Labialis (Oral Herpes) Introduction

11.9.4 Luoxin Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

11.9.5 Luoxin Recent Developments

11.10 Med shine

11.10.1 Med shine Company Details

11.10.2 Med shine Business Overview

11.10.3 Med shine Drugs for Herpes Labialis (Oral Herpes) Introduction

11.10.4 Med shine Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

11.10.5 Med shine Recent Developments

11.11 Bayer (Campho Phenique)

11.11.1 Bayer (Campho Phenique) Company Details

11.11.2 Bayer (Campho Phenique) Business Overview

11.11.3 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Introduction

11.11.4 Bayer (Campho Phenique) Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

11.11.5 Bayer (Campho Phenique) Recent Developments

11.12 Blistex

11.12.1 Blistex Company Details

11.12.2 Blistex Business Overview

11.12.3 Blistex Drugs for Herpes Labialis (Oral Herpes) Introduction

11.12.4 Blistex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

11.12.5 Blistex Recent Developments

11.13 Kelun

11.13.1 Kelun Company Details

11.13.2 Kelun Business Overview

11.13.3 Kelun Drugs for Herpes Labialis (Oral Herpes) Introduction

11.13.4 Kelun Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

11.13.5 Kelun Recent Developments

11.14 Hikma

11.14.1 Hikma Company Details

11.14.2 Hikma Business Overview

11.14.3 Hikma Drugs for Herpes Labialis (Oral Herpes) Introduction

11.14.4 Hikma Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

11.14.5 Hikma Recent Developments

11.15 Haiwang

11.15.1 Haiwang Company Details

11.15.2 Haiwang Business Overview

11.15.3 Haiwang Drugs for Herpes Labialis (Oral Herpes) Introduction

11.15.4 Haiwang Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

11.15.5 Haiwang Recent Developments

11.16 Carmex

11.16.1 Carmex Company Details

11.16.2 Carmex Business Overview

11.16.3 Carmex Drugs for Herpes Labialis (Oral Herpes) Introduction

11.16.4 Carmex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

11.16.5 Carmex Recent Developments

11.17 Cipher

11.17.1 Cipher Company Details

11.17.2 Cipher Business Overview

11.17.3 Cipher Drugs for Herpes Labialis (Oral Herpes) Introduction

11.17.4 Cipher Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

11.17.5 Cipher Recent Developments

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

    Table 2. Key Players of Aciclovir

    Table 3. Key Players of Valacyclovir

    Table 4. Key Players of Famciclovir

    Table 5. Key Players of Docosanol

    Table 6. Key Players of Other

    Table 7. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

    Table 8. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

    Table 9. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2019-2024) & (US$ Million)

    Table 10. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Region (2019-2024)

    Table 11. Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Region (2025-2030) & (US$ Million)

    Table 12. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Region (2025-2030)

    Table 13. Drugs for Herpes Labialis (Oral Herpes) Market Trends

    Table 14. Drugs for Herpes Labialis (Oral Herpes) Market Drivers

    Table 15. Drugs for Herpes Labialis (Oral Herpes) Market Challenges

    Table 16. Drugs for Herpes Labialis (Oral Herpes) Market Restraints

    Table 17. Global Drugs for Herpes Labialis (Oral Herpes) Revenue by Players (2019-2024) & (US$ Million)

    Table 18. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Players (2019-2024)

    Table 19. Global Top Drugs for Herpes Labialis (Oral Herpes) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Herpes Labialis (Oral Herpes) as of 2023)

    Table 20. Global Drugs for Herpes Labialis (Oral Herpes) Industry Ranking 2022 VS 2023 VS 2024

    Table 21. Global 5 Largest Players Market Share by Drugs for Herpes Labialis (Oral Herpes) Revenue (CR5 and HHI) & (2019-2024)

    Table 22. Global Key Players of Drugs for Herpes Labialis (Oral Herpes), Headquarters and Area Served

    Table 23. Global Key Players of Drugs for Herpes Labialis (Oral Herpes), Product and Application

    Table 24. Global Key Players of Drugs for Herpes Labialis (Oral Herpes), Product and Application

    Table 25. Mergers & Acquisitions, Expansion Plans

    Table 26. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2019-2024) & (US$ Million)

    Table 27. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Type (2019-2024)

    Table 28. Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Type (2025-2030) & (US$ Million)

    Table 29. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Type (2025-2030)

    Table 30. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2019-2024) & (US$ Million)

    Table 31. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Application (2019-2024)

    Table 32. Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Application (2025-2030) & (US$ Million)

    Table 33. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Application (2025-2030)

    Table 34. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2019-2024) & (US$ Million)

    Table 35. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2025-2030) & (US$ Million)

    Table 36. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2019-2024) & (US$ Million)

    Table 37. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2025-2030) & (US$ Million)

    Table 38. North America Drugs for Herpes Labialis (Oral Herpes) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 39. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024) & (US$ Million)

    Table 40. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2025-2030) & (US$ Million)

    Table 41. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2019-2024) & (US$ Million)

    Table 42. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2025-2030) & (US$ Million)

    Table 43. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2019-2024) & (US$ Million)

    Table 44. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2025-2030) & (US$ Million)

    Table 45. Europe Drugs for Herpes Labialis (Oral Herpes) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 46. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024) & (US$ Million)

    Table 47. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2025-2030) & (US$ Million)

    Table 48. China Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2019-2024) & (US$ Million)

    Table 49. China Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2025-2030) & (US$ Million)

    Table 50. China Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2019-2024) & (US$ Million)

    Table 51. China Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2025-2030) & (US$ Million)

    Table 52. Asia Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2019-2024) & (US$ Million)

    Table 53. Asia Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2025-2030) & (US$ Million)

    Table 54. Asia Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2019-2024) & (US$ Million)

    Table 55. Asia Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2025-2030) & (US$ Million)

    Table 56. Asia Drugs for Herpes Labialis (Oral Herpes) Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

    Table 57. Asia Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2019-2024) & (US$ Million)

    Table 58. Asia Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2025-2030) & (US$ Million)

    Table 59. Middle East, Africa, and Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2019-2024) & (US$ Million)

    Table 60. Middle East, Africa, and Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2025-2030) & (US$ Million)

    Table 61. Middle East, Africa, and Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2019-2024) & (US$ Million)

    Table 62. Middle East, Africa, and Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2025-2030) & (US$ Million)

    Table 63. Middle East, Africa, and Latin America Drugs for Herpes Labialis (Oral Herpes) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 64. Middle East, Africa, and Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024) & (US$ Million)

    Table 65. Middle East, Africa, and Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2025-2030) & (US$ Million)

    Table 66. GSK Company Details

    Table 67. GSK Business Overview

    Table 68. GSK Drugs for Herpes Labialis (Oral Herpes) Product

    Table 69. GSK Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024) & (US$ Million)

    Table 70. GSK Recent Developments

    Table 71. Novartis Company Details

    Table 72. Novartis Business Overview

    Table 73. Novartis Drugs for Herpes Labialis (Oral Herpes) Product

    Table 74. Novartis Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024) & (US$ Million)

    Table 75. Novartis Recent Developments

    Table 76. Teva Company Details

    Table 77. Teva Business Overview

    Table 78. Teva Drugs for Herpes Labialis (Oral Herpes) Product

    Table 79. Teva Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024) & (US$ Million)

    Table 80. Teva Recent Developments

    Table 81. Mylan Company Details

    Table 82. Mylan Business Overview

    Table 83. Mylan Drugs for Herpes Labialis (Oral Herpes) Product

    Table 84. Mylan Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024) & (US$ Million)

    Table 85. Mylan Recent Developments

    Table 86. Cadila Company Details

    Table 87. Cadila Business Overview

    Table 88. Cadila Drugs for Herpes Labialis (Oral Herpes) Product

    Table 89. Cadila Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024) & (US$ Million)

    Table 90. Cadila Recent Developments

    Table 91. Apotex Company Details

    Table 92. Apotex Business Overview

    Table 93. Apotex Drugs for Herpes Labialis (Oral Herpes) Product

    Table 94. Apotex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024) & (US$ Million)

    Table 95. Apotex Recent Developments

    Table 96. Daewoong Pharmaceutical Company Details

    Table 97. Daewoong Pharmaceutical Business Overview

    Table 98. Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Product

    Table 99. Daewoong Pharmaceutical Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024) & (US$ Million)

    Table 100. Daewoong Pharmaceutical Recent Developments

    Table 101. Livzon Company Details

    Table 102. Livzon Business Overview

    Table 103. Livzon Drugs for Herpes Labialis (Oral Herpes) Product

    Table 104. Livzon Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024) & (US$ Million)

    Table 105. Livzon Recent Developments

    Table 106. Luoxin Company Details

    Table 107. Luoxin Business Overview

    Table 108. Luoxin Drugs for Herpes Labialis (Oral Herpes) Product

    Table 109. Luoxin Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024) & (US$ Million)

    Table 110. Luoxin Recent Developments

    Table 111. Med shine Company Details

    Table 112. Med shine Business Overview

    Table 113. Med shine Drugs for Herpes Labialis (Oral Herpes) Product

    Table 114. Med shine Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024) & (US$ Million)

    Table 115. Med shine Recent Developments

    Table 116. Bayer (Campho Phenique) Company Details

    Table 117. Bayer (Campho Phenique) Business Overview

    Table 118. Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Product

    Table 119. Bayer (Campho Phenique) Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024) & (US$ Million)

    Table 120. Bayer (Campho Phenique) Recent Developments

    Table 121. Blistex Company Details

    Table 122. Blistex Business Overview

    Table 123. Blistex Drugs for Herpes Labialis (Oral Herpes) Product

    Table 124. Blistex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024) & (US$ Million)

    Table 125. Blistex Recent Developments

    Table 126. Kelun Company Details

    Table 127. Kelun Business Overview

    Table 128. Kelun Drugs for Herpes Labialis (Oral Herpes) Product

    Table 129. Kelun Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024) & (US$ Million)

    Table 130. Kelun Recent Developments

    Table 131. Hikma Company Details

    Table 132. Hikma Business Overview

    Table 133. Hikma Drugs for Herpes Labialis (Oral Herpes) Product

    Table 134. Hikma Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024) & (US$ Million)

    Table 135. Hikma Recent Developments

    Table 136. Haiwang Company Details

    Table 137. Haiwang Business Overview

    Table 138. Haiwang Drugs for Herpes Labialis (Oral Herpes) Product

    Table 139. Haiwang Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024) & (US$ Million)

    Table 140. Haiwang Recent Developments

    Table 141. Carmex Company Details

    Table 142. Carmex Business Overview

    Table 143. Carmex Drugs for Herpes Labialis (Oral Herpes) Product

    Table 144. Carmex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024) & (US$ Million)

    Table 145. Carmex Recent Developments

    Table 146. Cipher Company Details

    Table 147. Cipher Business Overview

    Table 148. Cipher Drugs for Herpes Labialis (Oral Herpes) Product

    Table 149. Cipher Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024) & (US$ Million)

    Table 150. Cipher Recent Developments

    Table 151. Research Programs/Design for This Report

    Table 152. Key Data Information from Secondary Sources

    Table 153. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

    Figure 2. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Type: 2023 VS 2030

    Figure 3. Aciclovir Features

    Figure 4. Valacyclovir Features

    Figure 5. Famciclovir Features

    Figure 6. Docosanol Features

    Figure 7. Other Features

    Figure 8. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

    Figure 9. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Application: 2023 VS 2030

    Figure 10. External Use Case Studies

    Figure 11. Oral Case Studies

    Figure 12. Injection Case Studies

    Figure 13. Drugs for Herpes Labialis (Oral Herpes) Report Years Considered

    Figure 14. Global Drugs for Herpes Labialis (Oral Herpes) Market Size (US$ Million), Year-over-Year: 2019-2030

    Figure 15. Global Drugs for Herpes Labialis (Oral Herpes) Market Size, (US$ Million), 2019 VS 2023 VS 2030

    Figure 16. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Region: 2023 VS 2030

    Figure 17. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Players in 2023

    Figure 18. Global Top Drugs for Herpes Labialis (Oral Herpes) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Herpes Labialis (Oral Herpes) as of 2023)

    Figure 19. The Top 10 and 5 Players Market Share by Drugs for Herpes Labialis (Oral Herpes) Revenue in 2023

    Figure 20. North America Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 21. North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2019-2030)

    Figure 22. North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2019-2030)

    Figure 23. North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2019-2030)

    Figure 24. United States Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 25. Canada Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 26. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size YoY (2019-2030) & (US$ Million)

    Figure 27. Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2019-2030)

    Figure 28. Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2019-2030)

    Figure 29. Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2019-2030)

    Figure 30. Germany Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 31. France Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 32. U.K. Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 33. Italy Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 34. Russia Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 35. Nordic Countries Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 36. China Drugs for Herpes Labialis (Oral Herpes) Market Size YoY (2019-2030) & (US$ Million)

    Figure 37. China Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2019-2030)

    Figure 38. China Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2019-2030)

    Figure 39. Asia Drugs for Herpes Labialis (Oral Herpes) Market Size YoY (2019-2030) & (US$ Million)

    Figure 40. Asia Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2019-2030)

    Figure 41. Asia Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2019-2030)

    Figure 42. Asia Drugs for Herpes Labialis (Oral Herpes) Market Share by Region (2019-2030)

    Figure 43. Japan Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 44. South Korea Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 45. China Taiwan Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 46. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 47. India Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 48. Australia Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 49. Middle East, Africa, and Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size YoY (2019-2030) & (US$ Million)

    Figure 50. Middle East, Africa, and Latin America Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2019-2030)

    Figure 51. Middle East, Africa, and Latin America Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2019-2030)

    Figure 52. Middle East, Africa, and Latin America Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2019-2030)

    Figure 53. Brazil Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 54. Mexico Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 55. Turkey Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 56. Saudi Arabia Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 57. Israel Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 58. GCC Countries Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 59. GSK Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

    Figure 60. Novartis Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

    Figure 61. Teva Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

    Figure 62. Mylan Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

    Figure 63. Cadila Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

    Figure 64. Apotex Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

    Figure 65. Daewoong Pharmaceutical Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

    Figure 66. Livzon Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

    Figure 67. Luoxin Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

    Figure 68. Med shine Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

    Figure 69. Bayer (Campho Phenique) Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

    Figure 70. Blistex Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

    Figure 71. Kelun Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

    Figure 72. Hikma Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

    Figure 73. Haiwang Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

    Figure 74. Carmex Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

    Figure 75. Cipher Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2019-2024)

    Figure 76. Bottom-up and Top-down Approaches for This Report

    Figure 77. Data Triangulation

    Figure 78. Key Executives Interviewed